Bioventus announced the appointment of Michael Minogue, Chief Executive Officer, President and Chairman of Abiomed Inc., to the company’s board of managers, replacing Dr. Evan Melrose. Minogue formerly served on the board of LifeCell Corporation (LIFC) and is one of the co-founders and Chairman of the MedTech and BioTech Veterans Program. He joined Abiomed after spending 11 years at General Electric Healthcare, where he also holds three patents.